uk 68798 has been researched along with Cardiovascular Stroke in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 8 (42.11) | 18.2507 |
2000's | 10 (52.63) | 29.6817 |
2010's | 1 (5.26) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baizman, ER; Becker, C; Bell, RH; Birsner, NC; Bohnet, EA; Busacca, CA; Carabateas, PM; Chadwick, CC; Gruett, MD; Johnson, RE | 1 |
Abildstrøm, SZ; Køber, L; Pedersen, OD; Schmiegelow, MD; Seibæk, M; Torp-Pedersen, C | 1 |
Burchardt, H; Hintze, U; Møller, M; Vach, W; Videbaek, J | 1 |
Bhatta, L; Hynes, J; Khan, M; Luck, J; Naccarelli, GV; Samii, S; Wolbrette, DL | 1 |
Brendorp, B; Elming, H; Jun, L; Køber, L; Torp-Pedersen, C | 1 |
Pratt, CM | 1 |
Cvetanovic, I; Ke, X; Lin, C; Ranade, V; Somberg, J | 1 |
Bhatia, GS; Lip, GY | 1 |
Feldman, S; Glikson, M; Levitan, J; Lewkowicz, M; Olesen, RM; Saermark, K; Thomsen, PE | 1 |
Brendorp, B; Burchardt, H; Elming, H; Køber, L; Pedersen, HS; Seibaek, M; Torp-Pedersen, C | 1 |
D'Alonzo, AJ; Darbenzio, RB; Dzwonczyk, S; Grover, GJ; Parham, CS | 1 |
Chen, J; Eto, K; Hashimoto, K; Ni, C; Xue, Y | 1 |
Møller, M | 1 |
Bugge, E; Løkebø, JE; Munch-Ellingsen, J; Ytrehus, K | 1 |
Agner, E; Bloch Thomsen, PE; Camm, AJ; Carlsen, J; Egstrup, K; Køber, L; Marchant, B; Møller, M; Sandøe, E; Torp-Pedersen, C; Videbaek, J | 1 |
Bagger, H; Keller, N; Køber, L; Marchant, B; Pedersen, OD; Torp-Pedersen, C | 1 |
Arrowsmith, JE; Blackburn, KJ; Burges, RA; Cross, PE; Dalrymple, HW; Gwilt, M; Higgins, AJ | 1 |
Corr, PB; Zuanetti, G | 1 |
3 review(s) available for uk 68798 and Cardiovascular Stroke
Article | Year |
---|---|
Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Australia; Canada; Controlled Clinical Trials as Topic; Europe; Flecainide; Heart Conduction System; Heart Failure; Humans; Multicenter Studies as Topic; Myocardial Infarction; Phenethylamines; Propafenone; Quinidine; Sotalol; Sulfonamides; Survival Analysis; Therapeutic Equivalency; Treatment Outcome; United States | 2003 |
Pure class III agents for prevention of sudden cardiac death.
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Comorbidity; Death, Sudden, Cardiac; Europe; Humans; Hydantoins; Imidazoles; Imidazolidines; Middle Aged; Myocardial Infarction; Phenethylamines; Piperazines; Randomized Controlled Trials as Topic; Sotalol; Sulfonamides; Survival Analysis; Treatment Outcome | 2003 |
Atrial fibrillation post-myocardial infarction: frequency, consequences, and management.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Heart Failure; Humans; Incidence; Myocardial Infarction; Phenethylamines; Potassium Channel Blockers; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Sulfonamides | 2004 |
6 trial(s) available for uk 68798 and Cardiovascular Stroke
Article | Year |
---|---|
The prognostic value of QTc interval and QT dispersion following myocardial infarction in patients treated with or without dofetilide.
Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Denmark; Double-Blind Method; Electrocardiography; Female; Follow-Up Studies; Humans; Long QT Syndrome; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Phenethylamines; Prognosis; Proportional Hazards Models; Risk Factors; Sulfonamides; Survival Analysis; Systole; Treatment Outcome; Ventricular Dysfunction, Left | 2003 |
Risk factors and predictors of Torsade de pointes ventricular tachycardia in patients with left ventricular systolic dysfunction receiving Dofetilide.
Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Output, Low; Cause of Death; Double-Blind Method; Electrocardiography; Female; Forecasting; Heart Arrest; Humans; Male; Middle Aged; Myocardial Infarction; Phenethylamines; Placebos; Potassium Channel Blockers; Risk Factors; Sex Factors; Sulfonamides; Time Factors; Torsades de Pointes; Ventricular Dysfunction, Left | 2007 |
DIAMOND antiarrhythmic trials. Danish Investigations of Arrhythmia and Mortality on Dofetilide.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Denmark; Heart Failure; Humans; Myocardial Infarction; Patient Selection; Phenethylamines; Risk; Sulfonamides | 1996 |
Dofetilide in patients with left ventricular dysfunction and either heart failure or acute myocardial infarction: rationale, design, and patient characteristics of the DIAMOND studies. Danish Investigations of Arrhythmia and Mortality ON Dofetilide.
Topics: Aged; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Denmark; Double-Blind Method; Female; Heart Failure; Humans; Male; Myocardial Infarction; Patient Selection; Phenethylamines; Potassium Channel Blockers; Research Design; Risk Factors; Sulfonamides; Ventricular Dysfunction, Left | 1997 |
Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial.
Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Double-Blind Method; Female; Humans; Male; Middle Aged; Myocardial Infarction; Phenethylamines; Sulfonamides; Ventricular Dysfunction, Left | 2000 |
Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (diamond) substudy.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Chronic Disease; Denmark; Double-Blind Method; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Phenethylamines; Sulfonamides; Survival Rate; Treatment Outcome; Ventricular Dysfunction, Left | 2001 |
10 other study(ies) available for uk 68798 and Cardiovascular Stroke
Article | Year |
---|---|
4,5-Dihydro-1-phenyl-1H-2,4-benzodiazepines: novel antiarrhythmic agents.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzodiazepines; Cats; Disease Models, Animal; Dogs; Guinea Pigs; Heart Ventricles; Male; Myocardial Contraction; Myocardial Infarction; Potassium Channels; Rats; Rats, Sprague-Dawley; Refractory Period, Electrophysiological; Sodium Channels; Structure-Activity Relationship | 1993 |
Incidence of atrial fibrillation in patients with either heart failure or acute myocardial infarction and left ventricular dysfunction: a cohort study.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Chi-Square Distribution; Cohort Studies; Denmark; Electrocardiography; Female; Heart Failure; Humans; Incidence; Kaplan-Meier Estimate; Male; Multicenter Studies as Topic; Myocardial Infarction; Phenethylamines; Proportional Hazards Models; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Assessment; Risk Factors; Stroke Volume; Sulfonamides; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left | 2011 |
QT interval dynamics predict mortality in high-risk patients after myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography, Ambulatory; Female; Follow-Up Studies; Heart Rate; Humans; Male; Multivariate Analysis; Myocardial Infarction; Observer Variation; Phenethylamines; Predictive Value of Tests; Prospective Studies; Risk Factors; Sulfonamides; Survival Analysis; Treatment Outcome; Ventricular Dysfunction, Left | 2002 |
The influence of extracellular acidosis on the effect of IKr blockers.
Topics: Acidosis; Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Dose-Response Relationship, Drug; Humans; Hydantoins; Imidazolidines; Myocardial Infarction; Oocytes; Phenethylamines; Piperazines; Potassium Channels; Potassium Channels, Voltage-Gated; Quinidine; Sulfonamides; Trans-Activators; Xenopus laevis | 2005 |
Statistical analysis of the DIAMOND MI study by the multipole method.
Topics: Double-Blind Method; Electrocardiography; Heart Rate; Humans; Myocardial Infarction; Phenethylamines; Randomized Controlled Trials as Topic; Statistics as Topic; Sulfonamides | 2005 |
Preconditioning is not abolished by the delayed rectifier K+ blocker dofetilide.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Coronary Circulation; Dogs; Dose-Response Relationship, Drug; Female; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Phenethylamines; Pilot Projects; Potassium; Reaction Time; Sulfonamides | 1996 |
Effects of dofetilide, a class III antiarrhythmic drug, on various ventricular arrhythmias in dogs.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Vessels; Digitalis; Disease Models, Animal; Dogs; Electric Stimulation; Electrocardiography; Epinephrine; Female; Male; Myocardial Infarction; Myocardial Reperfusion; Phenethylamines; Plants, Medicinal; Plants, Toxic; Sulfonamides; Tachycardia, Ventricular; Ventricular Fibrillation | 1996 |
Potassium channel blocker dofetilide does not abolish ischaemic preconditioning.
Topics: Animals; Anti-Arrhythmia Agents; Electrophysiology; Hemodynamics; Ischemic Preconditioning, Myocardial; Myocardial Infarction; Phenethylamines; Potassium Channel Blockers; Rabbits; Risk Factors; Sulfonamides | 1997 |
UK-68,798: a novel, potent and highly selective class III antiarrhythmic agent which blocks potassium channels in cardiac cells.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Dogs; Evaluation Studies as Topic; Guinea Pigs; Heart; Heart Ventricles; Male; Membrane Potentials; Myocardial Infarction; Myocardium; Papillary Muscles; Phenethylamines; Potassium Channels; Purkinje Fibers; Sulfonamides; Ventricular Function | 1991 |
Antiarrhythmic efficacy of a new class III agent, UK-68,798, during chronic myocardial infarction: evaluation using three-dimensional mapping.
Topics: Animals; Anti-Arrhythmia Agents; Blood Pressure; Dogs; Electric Stimulation; Electrocardiography; Heart; Heart Conduction System; Heart Ventricles; Myocardial Infarction; Phenethylamines; Sulfonamides; Tachycardia; Ventricular Fibrillation | 1991 |